Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results